Tobias Göldi1, Philipp Krisai1, Sven Knecht1, Stefanie Aeschbacher1, Florian Spies1, Ivan Zeljkovic2, Beat A Kaufmann1, Beat Schaer1, David Conen3, Tobias Reichlin4, Stefan Osswald1, Christian Sticherling1, Michael Kühne5. 1. Department of Cardiology, University Hospital of Basel, Basel, Switzerland; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland. 2. Sestre Milosrdnice University Hospital, Zagreb, Croatia. 3. Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland; Population Health Research Institute, McMaster University and Department of Cardiology, Hamilton Health Sciences, Hamilton, Ontario, Canada. 4. Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. 5. Department of Cardiology, University Hospital of Basel, Basel, Switzerland; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland. Electronic address: michael.kuehne@usb.ch.
Abstract
OBJECTIVES: This study aimed to investigate the prevalence and management of left atrial (LA) thrombi detected by transesophageal echocardiography (TEE) in patients with atrial fibrillation undergoing pulmonary vein isolation (PVI). BACKGROUND: Little data are available on LA thrombi before PVI. METHODS: All patients scheduled for PVI between April 2010 and April 2018 undergoing pre-procedural TEE were analyzed. Management of LA thrombus was at the discretion of the treating physician. RESULTS: In this study, 1,753 pre-procedural TEE from 1,358 patients (mean age 61 ± 10 years, 28% female) were included. Anticoagulation was used in 86% of all TEE (51% with direct oral anticoagulants [DOAC], 35% with vitamin K antagonists [VKA]). Thrombi were found in 11 TEE (0.6%), all in the LA appendage. Of the 11 patients with a thrombus, 5 (46%) had paroxysmal atrial fibrillation, 2 (18%) had a CHA2DS2-VASc (Congestive Heart Failure, Hypertension, Age ≥75 Years, Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack or Thromboembolism, Vascular Disease, Age 65 to 74 Years, Sex) score of 1, and 5 (46%) were in sinus rhythm at the time of TEE. Of the 8 patients (72%) on anticoagulation therapy, 5 were treated with DOAC and 3 with VKA. Starting anticoagulation (n = 3), switching to VKA with a target international normalized ratio of 2.5 to 3 (n = 3), or switching to a DOAC (n = 1) or a different DOAC (n = 4) resulted in thrombus resolution in 9 of 11 patients (82%). CONCLUSIONS: In patients with atrial fibrillation scheduled for PVI, LA thrombi are rare and present in <1%. Thrombi were found in patients on VKA and DOAC, in low-risk patients, and despite sinus rhythm. Thrombus resolution was achieved in the majority of patients by changing the anticoagulation regimen.
OBJECTIVES: This study aimed to investigate the prevalence and management of left atrial (LA) thrombi detected by transesophageal echocardiography (TEE) in patients with atrial fibrillation undergoing pulmonary vein isolation (PVI). BACKGROUND: Little data are available on LA thrombi before PVI. METHODS: All patients scheduled for PVI between April 2010 and April 2018 undergoing pre-procedural TEE were analyzed. Management of LA thrombus was at the discretion of the treating physician. RESULTS: In this study, 1,753 pre-procedural TEE from 1,358 patients (mean age 61 ± 10 years, 28% female) were included. Anticoagulation was used in 86% of all TEE (51% with direct oral anticoagulants [DOAC], 35% with vitamin K antagonists [VKA]). Thrombi were found in 11 TEE (0.6%), all in the LA appendage. Of the 11 patients with a thrombus, 5 (46%) had paroxysmal atrial fibrillation, 2 (18%) had a CHA2DS2-VASc (Congestive Heart Failure, Hypertension, Age ≥75 Years, Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack or Thromboembolism, Vascular Disease, Age 65 to 74 Years, Sex) score of 1, and 5 (46%) were in sinus rhythm at the time of TEE. Of the 8 patients (72%) on anticoagulation therapy, 5 were treated with DOAC and 3 with VKA. Starting anticoagulation (n = 3), switching to VKA with a target international normalized ratio of 2.5 to 3 (n = 3), or switching to a DOAC (n = 1) or a different DOAC (n = 4) resulted in thrombus resolution in 9 of 11 patients (82%). CONCLUSIONS: In patients with atrial fibrillation scheduled for PVI, LA thrombi are rare and present in <1%. Thrombi were found in patients on VKA and DOAC, in low-risk patients, and despite sinus rhythm. Thrombus resolution was achieved in the majority of patients by changing the anticoagulation regimen.
Authors: Felix K Wegner; Robert Radke; Christian Ellermann; Julian Wolfes; Alicia J Fischer; Helmut Baumgartner; Lars Eckardt; Gerhard-Paul Diller; Stefan Orwat Journal: Sci Rep Date: 2022-03-07 Impact factor: 4.379
Authors: Shaobo Shi; Qingyan Zhao; Tao Liu; Shujuan Zhang; Jinjun Liang; Yanhong Tang; Bo Yang; He Huang; Congxin Huang Journal: Front Cardiovasc Med Date: 2022-05-02
Authors: Felix K Wegner; Robert M Radke; Christian Ellermann; Julian Wolfes; Kevin Willy; Philipp S Lange; Gerrit Frommeyer; Helmut Baumgartner; Lars Eckardt; Gerhard-Paul Diller; Stefan Orwat Journal: J Pers Med Date: 2022-03-14